Umbrella_KeckMedicine
umbrella-logo
Keck Medicine of USC is the University of Southern California’s medical enterprise, one of only two university-owned academic medical centers in the Los Angeles area.

mjmedina

About mjmedina

This author has not yet filled in any details.
So far mjmedina has created 9 blog entries.

USC Norris Cancer Center earns best-ever rating from National Cancer Institute

The USC Norris Comprehensive Cancer Center has received an elite score from the National Cancer Institute as part of its five-year core grant renewal process. The June site review produced the best result ever for the prestigious medical facility situated on USC’s Health Sciences Campus, earning an “outstanding” distinction from the NCI reviewers. “This highly ...   Read More »

Saving Life and Limb

As a teenager, Robert Dobbie loved to surf. The Hermosa Beach, CA, native learned to longboard and boogie board, and along with his friends, he’d enter local surfing competitions to see how he stacked up against other wave-catchers. “It was just going out there and having fun,” says the now 40-year-old father of three. “We ...   Read More »

Keck Medicine of USC supports draft Medicare proposal for lung cancer screenings

With the recent draft decision by the Centers for Medicare and Medicaid (CMS) to cover 100 percent of costs for annual lung cancer screenings for patients age 55 to 74 with a 30-year smoking history, Keck Medicine of the University of Southern California’s (USC) Multidisciplinary Lung Cancer program supports the move to increase awareness, prevention ...   Read More »

USC Institute of Urology honors prostate cancer survivor at “Changing Lives and Creating Cures” Gala

The USC Institute of Urology, one of the nation’s top-ranked urology programs, honored Derrick Hall, president and CEO of the Arizona Diamondbacks major league baseball franchise, a native son of Los Angeles and a prostate cancer survivor and advocate, with the inaugural Louis Zamperini Courage Award at its annual “Changing Lives and Creating Cures” gala, ...   Read More »

USC Stem Cell researcher targets ‘seeds’ of breast cancer metastasis

For breast cancer patients, the era of personalized medicine may be just around the corner, thanks to recent advances by USC Stem Cell researcher Min Yu, MD, PhD, and scientists at Massachusetts General Hospital and Harvard Medical School. In a July 10 study in Science, Yu and her colleagues report how they isolated breast cancer ...   Read More »

USC surgeons perform novel robotic-assisted prostate cancer operation

Surgeons at the Keck Medical Center of USC became the first in California to use the latest minimally invasive surgical system for prostate cancer when they performed a robotic-assisted procedure in July. The surgery further cements the Los Angeles-based university hospitals’ position as a global center of excellence for robotic surgery. The procedure used the ...   Read More »

USC surgeons perform novel robotic-assisted prostate cancer operation

Surgeons at the Keck Medical Center of USC became the first in California to use the latest minimally invasive surgical system for prostate cancer when they performed a robotic-assisted procedure in July. The surgery further cements the Los Angeles-based university hospitals’ position as a global center of excellence for robotic surgery. The procedure used the ...   Read More »

Keck Medical Center of USC physician leads new study on genomics of young lung cancer

Barbara Gitlitz, MD, associate professor of medicine at the Keck School of Medicine of USC and members of the USC Norris Comprehensive Cancer Center, is leading a new clinical study to understand why lung cancer occurs in adults under 40 who are athletic, were never smokers and do not exhibit any of the known lung ...   Read More »

Keck Medicine of USC researchers discover dual purpose of cancer drug in regulating expression of genes

Keck Medicine of USC scientists have discovered new clues about a drug instrumental in treating a certain blood cancer that may provide important targets for researchers searching for cures. The team investigated whether demethylation of gene bodies induced by the drug 5-Aza-CdR (decitabine), which is used to treat pre-leukemia, could alter gene expression and possibly ...   Read More »